Published JUL 7, 2026

CGM Adhesive Patch Brand, 10-Year Amazon Diabetes Accessory Seller

$1.7M
Revenue
$539K
SDE
3.2x
Multiple
Subscribe Free

Read the full deal writeup

Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a 10-year-old e-commerce brand selling adhesive patches and accessories that secure continuous glucose monitoring (CGM) devices worn by people managing diabetes. Founded in 2015, the business sells over 95% through Amazon with a smaller Shopify channel, and it has carved out a specialization in adhesion strength and reliability for active wearers who exercise, swim, or need extended wear without skin irritation. The product solves a real, recurring problem: CGM sensors and their adhesives fail or peel, and users replace patches on a regular cycle.

The financial profile is clean for a $1.7M asking price. On $1.72M of revenue the business throws off $538,729 of SDE, a 30%+ margin, at a 3.16x multiple that is SBA pre-qualified. Roughly 31% of revenue comes from repeat purchases, which is a strong signal in a consumables category where CGM adhesion is an ongoing, non-negotiable need rather than a one-time buy.

What makes it notable is the intersection of a boring, essential consumable with a genuinely growing end market. CGM adoption is expanding rapidly across both Type 1 and Type 2 diabetes and into broader metabolic health, and every new sensor wearer becomes a candidate for recurring adhesive purchases. The brand rides that tailwind without carrying device-level regulatory or manufacturing complexity.

Why we like it

  • Earnings quality is solid: $538,729 SDE on $1.72M revenue is a 31% margin, and the listing frames owner workload as low, which means the SDE is not disguised owner labor. At 3.16x and SBA pre-qualified, a buyer can finance most of the price and clear debt service comfortably from cash flow.
  • Durability comes from the consumable nature of the product. CGM adhesives peel, sweat off, and get replaced on a recurring cycle, so 31% repeat-purchase revenue reflects real biological need rather than brand fashion. This is the rare Amazon brand where customers must come back.
  • Market tailwinds are genuine and multi-year. CGM adoption is expanding well beyond Type 1 diabetes into Type 2 and general metabolic health, and every incremental sensor wearer is a new candidate for adhesive patches. The brand grows simply by riding device adoption it does not have to fund.
  • The operator advantage is a low-complexity accessory sitting adjacent to a heavily regulated device category. You get the recurring demand of a medical consumable without the FDA burden, R&D cost, or capital intensity of making the sensor itself. That is an attractive spot on the value chain.

How to improve it

  • Attack the subscription and lifecycle gap directly. With only 31% of revenue repeat despite an inherently recurring product, there is clear room to convert one-time buyers into Subscribe & Save and Shopify subscription cohorts. Even moving repeat revenue from 31% to 45% materially raises LTV and enterprise value.
  • Launch patches for newly released CGM devices before competitors. Each new Dexcom, Abbott, or Medtronic sensor shape creates a fresh SKU opportunity, and being first to list the compatible patch captures the review flywheel early. Build a standing process to design and launch within weeks of each device release.
  • Diversify off Amazon dependence. At 95%+ concentration on one channel, the business is one policy change or listing suspension away from a cash flow shock. Grow the Shopify DTC base, build an email and SMS file, and test retail placement in pharmacies to reduce single-platform risk.
  • Expand into adjacent diabetes accessory categories. Insulin pump patches, sensor covers, skin prep wipes, and adhesive removers all target the same customer with the same buying behavior. Cross-sell to the existing base to lift average order value with minimal new customer acquisition cost.
  • Pursue international expansion where CGM adoption is accelerating. Amazon marketplaces in the UK, EU, Canada, and Australia serve growing diabetic populations, and the product needs no reformulation. Replicating winning listings abroad is a low-cost lever on a proven catalog.
  • Tighten pricing and bundle strategy. Multi-pack and bundle SKUs raise units per order and improve margin against Amazon fees. Test premium bundles for active users (swimmers, athletes) who value the brand's adhesion strength most and are least price-sensitive.

Diligence notes

  • Verify the 31% repeat-purchase figure and the source of that data. Confirm whether it is measured from Amazon Subscribe & Save, matched email addresses, or Shopify accounts, and pull the actual cohort retention curves. The repeat rate is central to the valuation thesis, so it must be documented, not asserted.
  • Scrutinize Amazon account health and concentration risk. Review the full history of listing suspensions, IP or safety complaints, account warnings, and reviews velocity. A single account tied to 95%+ of revenue is the primary point of failure in this deal.
  • Examine supplier and manufacturing dependence. Identify whether the adhesive patches come from one factory, what the terms and lead times are, and whether any IP, tooling, or exclusive formulation protects against a supplier going direct or a competitor copying the product.
  • Assess regulatory and product-liability exposure. Adhesive patches worn on skin near a medical device can trigger FDA classification questions, labeling claims scrutiny, and skin-irritation liability. Confirm current classification, insurance coverage, and any past complaints or adverse events.
  • Test durability against CGM device changes. Because SKUs are tied to specific sensor shapes, confirm what share of revenue depends on legacy devices being phased out versus current-generation sensors. A device redesign could obsolete top SKUs, so understand the SKU-level revenue and roadmap risk.

Source

Originally listed on BizBuySell. View original listing →

Want the full analysis on every deal? Unlock the complete platform with Accredited Pro to screen live listings and read our operator-level writeups.